Home/Filings/4/0001415889-25-018277
4//SEC Filing

HOUGEN ELIZABETH L 4

Accession 0001415889-25-018277

CIK 0001817241other

Filed

Jun 25, 8:00 PM ET

Accepted

Jun 26, 4:30 PM ET

Size

5.6 KB

Accession

0001415889-25-018277

Insider Transaction Report

Form 4
Period: 2025-06-24
Transactions
  • Award

    Director Stock Option (Right to Buy)

    2025-06-24+13,75013,750 total
    Exercise: $1.61Exp: 2035-06-23Common Stock (13,750 underlying)
Footnotes (1)
  • [F1]The shares subject to the option will vest in full on the earlier of June 24, 2026, or the date of the Issuer's 2026 annual stockholder meeting.

Issuer

Artiva Biotherapeutics, Inc.

CIK 0001817241

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001074773

Filing Metadata

Form type
4
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 4:30 PM ET
Size
5.6 KB